Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
VYGR · against 110 other Healthcare companies of similar size
Ranked #77 of 111 · scores higher than 6% of peers
Bars: peers in each 10-point band of the valuation score35 peers with a valuation score of 0–9, including VYGR · Click a bar to see the companies
Mainly because of its EBITDA yield, free cash flow yield and earnings yield, which are weaker than most Healthcare peers.
| Metric | VYGR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 95 reported | -98.9% | -13.0% | 12% | 30% | |
| EBITDA yieldHigher is better · 118 reported | -375.0% | -2.1% | 10% | 50% | |
| Free cash flow yieldHigher is better · 83 reported | -107.7% | -15.7% | 4% | 20% | |
| Book yieldHigher is better · 99 reported | 137.7% | 70.2% | 69% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 834M HKD (≈$107M) | 99 | 57 | |
| 1 | 1.4B HKD (≈$181M) | 99 | 61 | |
| 1 | 29.0B JPY (≈$197M) | 99 | 56 | |
| 1 | 592M ILS (≈$160M) | 99 | 84 | |
| 77 | 170M USD | 8 | 35 | |
| 77 | 139M USD | 8 | 32 | |
| 77 | 223M USD | 8 | 34 | |
| 77 | 172M USD | 8 | 34 | |
| 77 | 113M USD | 8 | 23 | |
| 105 | 580M HKD (≈$74M) | 0 | 7 | |
| 105 | 10.8B JPY (≈$73M) | 0 | 27 | |
| 105 | 8.4B JPY (≈$57M) | 0 | ||
| 105 | 106M EUR (≈$116M) | 0 | 46 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score